UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Medications as a Potential Source of Exposure to Phthalates in the U.S. Population

Environmental health perspectives, 2009-02, Vol.117 (2), p.185-189

2009

Volltextzugriff (PDF)

Bifunctional Peptidomimetic Prodrugs of Didanosine for Improved Intestinal Permeability and Enhanced Acidic Stability: Synthesis, Transepithelial Transport, Chemical Stability and Pharmacokinetics

Molecular pharmaceutics, 2011-04, Vol.8 (2), p.319-329

2011

Volltextzugriff (PDF)

Selection and Characterization of Suitable Lipid Excipients for use in the Manufacture of Didanosine-Loaded Solid Lipid Nanoparticles and Nanostructured Lipid Carriers

Journal of pharmaceutical sciences, 2011-12, Vol.100 (12), p.5185-5196

2011

Volltextzugriff (PDF)

Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors

AIDS (London), 2019-03, Vol.33 (4), p.675-683

2019

Volltextzugriff (PDF)

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

AIDS (London), 2012-01, Vol.26 (3), p.303-314

2012

Volltextzugriff (PDF)

Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine

AIDS (London), 2016-07, Vol.30 (11), p.1771-1780

2016

Volltextzugriff (PDF)

Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses

Journal of drug targeting, 2010-06, Vol.18 (5), p.381-388

2010

Volltextzugriff (PDF)

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

The Lancet (British edition), 2008-04, Vol.371 (9622), p.1417-1426

2008

Volltextzugriff (PDF)

DIDANOSINE RETINAL TOXICITY

Retina (Philadelphia, Pa.), 2016-12, Vol.36 (Supplement 1), p.S159-S167

2016

Volltextzugriff (PDF)

Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies

Biomaterials, 2013-07, Vol.34 (20), p.4831-4838

2013

Volltextzugriff (PDF)

Surface amplification of pencil graphite electrode with polypyrrole and reduced graphene oxide for fabrication of a guanine/adenine DNA based electrochemical biosensors for determination of didanosine anticancer drug

Applied surface science, 2018-05, Vol.441, p.55-60

2018

Volltextzugriff (PDF)

Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study

PloS one, 2019-01, Vol.14 (1), p.e0211354-e0211354

2019

Volltextzugriff (PDF)

Synthesis and Antiviral Activity of Novel Phosphorylated Derivatives of Didanosine Against Newcastle Disease Virus in Chicken

Archiv der Pharmazie (Weinheim), 2016-06, Vol.349 (6), p.442-455

2016

Volltextzugriff (PDF)

Squalenoylation: A generic platform for nanoparticular drug delivery

Journal of controlled release, 2012-07, Vol.161 (2), p.609-618

2012

Volltextzugriff (PDF)

Sustainable Protocol for the Synthesis of 2′,3′-Dideoxynucleoside and 2′,3′-Didehydro-2′,3′-dideoxynucleoside Derivatives

Molecules (Basel, Switzerland), 2022-06, Vol.27 (13), p.3993

2022

Volltextzugriff (PDF)

The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study

Journal of acquired immune deficiency syndromes (1999), 2010-03, Vol.53 (3), p.369-377

2010

Volltextzugriff (PDF)

A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary

International journal of pharmaceutics, 2011-07, Vol.414 (1), p.285-297

2011

Volltextzugriff (PDF)

Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery

Nanomedicine, 2008-03, Vol.4 (1), p.41-48

2008

Volltextzugriff (PDF)

Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: In vitro and in vivo evaluation

Acta pharmaceutica (Zagreb, Croatia), 2008-03, Vol.58 (1), p.61-74

2008

Volltextzugriff (PDF)

Self-assembled drug delivery systems: Part 3. In vitro/in vivo studies of the self-assembled nanoparticulates of cholesteryl acyl didanosine

International journal of pharmaceutics, 2009-02, Vol.368 (1-2), p.207-214

2009

Volltextzugriff (PDF)

Combination Anti-HIV Therapy with the Self-Assemblies of an Asymmetric Bolaamphiphilic Zidovudine/Didanosine Prodrug

Molecular pharmaceutics, 2011-06, Vol.8 (3), p.867-876

2011

Volltextzugriff (PDF)

MULTIMODAL IMAGING IN DIDANOSINE RETINOPATHY

Retinal cases & brief reports, 2021-05, Vol.15 (3), p.234-238

2021

Volltextzugriff (PDF)

Risk of cancer in children exposed to antiretroviral nucleoside analogues in utero: The french experience

Environmental and molecular mutagenesis, 2019-06, Vol.60 (5), p.404-409

2019

Volltextzugriff (PDF)

Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study

PloS one, 2012-09, Vol.7 (9), p.e44575

2012

Volltextzugriff (PDF)

Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir

The Journal of infectious diseases, 2020-06, Vol.222 (1), p.54-61

2020

Volltextzugriff (PDF)

1 – 25 von 2.229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.835)
Mit Volltextzugriff
(1.511)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(1.832)
Science & Technology
(1.481)
Life Sciences & Biomedicine
(1.424)
Aids/hiv
(1.322)
Hiv Infections - Drug Therapy
(1.107)
Didanosine - Therapeutic Use
(1.059)
Biological And Medical Sciences
(939)
Medical Sciences
(905)
Male
(810)
Female
(707)
Pharmacology. Drug Treatments
(690)
Drug Therapy, Combination
(670)
Adult
(669)
Infectious Diseases
(669)
Zidovudine - Therapeutic Use
(605)
Didanosine
(575)
Antiviral Agents
(574)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(549)
Anti-Hiv Agents - Therapeutic Use
(545)
Didanosine - Administration & Dosage
(530)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Medications as a Potential Source of Exposure to Phthalates in the U.S. Population

Bifunctional Peptidomimetic Prodrugs of Didanosine for Improved Intestinal Permeability and Enhanced Acidic Stability: Synthesis, Transepithelial Transport, Chemical Stability and Pharmacokinetics

Selection and Characterization of Suitable Lipid Excipients for use in the Manufacture of Didanosine-Loaded Solid Lipid Nanoparticles and Nanostructured Lipid Carriers

Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine

Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

DIDANOSINE RETINAL TOXICITY

Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies

Surface amplification of pencil graphite electrode with polypyrrole and reduced graphene oxide for fabrication of a guanine/adenine DNA based electrochemical biosensors for determination of didanosine anticancer drug

Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study

Synthesis and Antiviral Activity of Novel Phosphorylated Derivatives of Didanosine Against Newcastle Disease Virus in Chicken

Squalenoylation: A generic platform for nanoparticular drug delivery

Sustainable Protocol for the Synthesis of 2′,3′-Dideoxynucleoside and 2′,3′-Didehydro-2′,3′-dideoxynucleoside Derivatives

The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study

A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary

Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery

Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: In vitro and in vivo evaluation

Self-assembled drug delivery systems: Part 3. In vitro/in vivo studies of the self-assembled nanoparticulates of cholesteryl acyl didanosine

Combination Anti-HIV Therapy with the Self-Assemblies of an Asymmetric Bolaamphiphilic Zidovudine/Didanosine Prodrug

MULTIMODAL IMAGING IN DIDANOSINE RETINOPATHY

Risk of cancer in children exposed to antiretroviral nucleoside analogues in utero: The french experience

Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study

Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir

Suchergebnisse filtern